409 related articles for article (PubMed ID: 28289080)
1. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
Smith B; Agarwal P; Bhowmick NA
Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.
Khan S; Ayub H; Khan T; Wahid F
Biochimie; 2019 Dec; 167():12-24. PubMed ID: 31493469
[TBL] [Abstract][Full Text] [Related]
3. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
Zou J; Yin F; Wang Q; Zhang W; Li L
Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs Role in Prostate Cancer.
Balacescu O; Dumitrescu RG; Marian C
Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
[TBL] [Abstract][Full Text] [Related]
5. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
[TBL] [Abstract][Full Text] [Related]
6. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
Saumet A; Lecellier CH
Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
[TBL] [Abstract][Full Text] [Related]
7. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy in cancer.
Tsimberidou AM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
[TBL] [Abstract][Full Text] [Related]
9. The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment.
Davey MG; Davies M; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361056
[TBL] [Abstract][Full Text] [Related]
10. Functional role of microRNAs in prostate cancer and therapeutic opportunities.
Maugeri-Sacca M; Coppola V; De Maria R; Bonci D
Crit Rev Oncog; 2013; 18(4):303-15. PubMed ID: 23614617
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
12. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
Le Tourneau C; Kamal M; Tsimberidou AM; Bedard P; Pierron G; Callens C; Rouleau E; Vincent-Salomon A; Servant N; Alt M; Rouzier R; Paoletti X; Delattre O; Bièche I
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598514
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer in 2016: Improved outcomes and precision medicine come within reach.
Sternberg CN; Beltran H
Nat Rev Urol; 2017 Feb; 14(2):71-72. PubMed ID: 28050016
[No Abstract] [Full Text] [Related]
14. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
Gordanpour A; Nam RK; Sugar L; Seth A
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
[TBL] [Abstract][Full Text] [Related]
15. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Stover DG; Wagle N
Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
[TBL] [Abstract][Full Text] [Related]
16. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
17. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
Andre F; Vicier C; Delaloge S
Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
[TBL] [Abstract][Full Text] [Related]
18. microRNA and Ovarian Cancer.
Langhe R
Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
[TBL] [Abstract][Full Text] [Related]
19. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
[No Abstract] [Full Text] [Related]
20. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
Kumar B; Lupold SE
Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
